Medicines & Treatments
Vip 6 mg
Dragon Pharma VIP 6 mg – Synthetic Vasoactive Intestinal Peptide for Research ✔ Synthetic 28-amino-acid neuropeptide ✔ Potent vasodilator and neurotransmitter ✔ Immune system regulator ✔ USA domestic shipping available Dragon Pharma VIP 6 mg is a synthetic form of Vasoactive Intestinal Peptide (VIP), a 28-amino-acid human neuropeptide hormone that functions as a potent vasodilator, neurotransmitter, and immune system regulator. Produced naturally in the gastrointestinal tract, pancreas, and brain, VIP plays critical roles in smooth muscle relaxation, fluid and electrolyte secretion, and the modulation of inflammatory responses. Each vial contains 6 mg of lyophilized VIP in a 2 mL format, requiring reconstitution with bacteriostatic water before use. This peptide has been extensively studied for its diverse biological activities, including vasodilation, neuroprotection, immunomodulation, and regulation of digestive and respiratory functions. For related research compounds, explore our peptides category and specifically Semax for complementary neuropeptide research applications. What Makes VIP Valuable in Research? VIP is a pleiotropic neuropeptide with a wide range of biological effects. Its ability to act as a potent vasodilator, relax smooth muscle, and modulate immune responses makes it a valuable research tool for investigating multiple physiological systems. VIP interacts with specific receptors (VPAC1 and VPAC2) that are widely distributed throughout the body, enabling its diverse functions. Researchers value VIP for its versatility and its role in connecting nervous, endocrine, and immune systems. Its involvement in conditions ranging from inflammation and autoimmune disorders to gastrointestinal and respiratory function makes it relevant to numerous research areas. For investigators exploring immune-modulating peptides, Thymosin Alpha-1 offers complementary research avenues in immune system regulation. Current scientific literature on VIP can be accessed through the PubMed database, where researchers can review peer-reviewed studies on its biological activity and experimental applications. Key Research Applications for Dragon Pharma VIP ✔ Investigation of vasodilation and vascular regulation ✔ Evaluation of smooth muscle relaxation mechanisms ✔ Research on immune system modulation and inflammation ✔ Studies of gastrointestinal and respiratory physiology ✔ Preclinical models of neuroprotection and neural function For Research Purposes Only VIP 6 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on gastrointestinal function, BPC 157 provides additional research avenues in digestive tissue protection.
Vilon 20 mg
Vilon 20 mg – Cytogenetic Immune-Rejuvenating Peptide | Peptide Hubs Vilon is a short-chain synthetic peptide bioregulator derived from thymic extracts, studied for its gene-modulating, immune-balancing, and longevity-enhancing properties. This 20 mg (2 mL) vial formulation by Peptide Hubs is intended for research use only and is manufactured to GMP specifications. Vilon is a core component in peptide gerontology research due to its impact on nuclear gene expression and tissue-specific cellular restoration. What Is Vilon? Vilon is classified as a cytogenetic peptide that can influence gene transcription by interacting directly with nuclear DNA. It promotes chromatin remodeling and helps stabilize cellular functions in aging or damaged tissues. It is of particular interest in research involving immunosenescence, autoimmunity, and chronic degenerative conditions. In a PubMed study, Vilon demonstrated significant activity in normalizing gene expression patterns in immunocompromised models. Key Research Applications Rejuvenation of the immune system in aging models Regulation of gene expression and chromatin stability Tissue regeneration in damaged or inflamed organs Epigenetic support for cell differentiation and apoptosis control Synergistic use in longevity and gerontology studies
Vesugen 20 mg
Dragon Pharma Vesugen 20 mg – Synthetic Tripeptide for Vascular Research ✔ Synthetic KED tripeptide bioregulator ✔ Khavinson peptide class compound ✔ Studied for vascular endothelial function ✔ USA domestic shipping available Dragon Pharma Vesugen 20 mg is a synthetic tripeptide bioregulator with the amino acid sequence Lys-Glu-Asp (KED). Developed within the well-established Khavinson peptide framework, this compound has been investigated in laboratory settings for its potential effects on vascular endothelial cells, microcirculation, and age-related changes in blood vessel walls. Each vial contains 20 mg of lyophilized Vesugen in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Vesugen represents a targeted research tool for investigating vascular biology, endothelial function, and the molecular mechanisms underlying vascular aging and microcirculatory health. For related research compounds, explore our peptides category and specifically Cardiogen for complementary cardiovascular research applications. What Makes Vesugen Valuable in Research? Vesugen belongs to a class of short-chain peptides known for their tissue-specific bioregulatory properties. The KED sequence has been studied for its ability to influence cellular processes relevant to vascular health, including endothelial cell function, microcirculatory dynamics, and the vascular changes associated with aging. Its defined sequence and mechanism of action make it a practical tool for investigating the molecular basis of vascular regulation. Researchers value Vesugen for its targeted approach to studying vascular biology. Its ability to modulate endothelial cell activity and microcirculation provides insights into the mechanisms that govern vascular health and age-related vascular changes. For investigators exploring other areas of vascular research, MOTS-C offers complementary research avenues in metabolic and vascular function studies. Current scientific literature on Khavinson peptides, including Vesugen, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications. Key Research Applications for Dragon Pharma Vesugen ✔ Investigation of vascular endothelial cell function ✔ Evaluation of microcirculation and blood flow dynamics ✔ Research on age-related vascular changes ✔ Studies of peptide bioregulation in vascular models ✔ Preclinical models of vascular health and aging For Research Purposes Only Vesugen 20 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on vascular repair, TB 500 provides additional research avenues in angiogenesis and tissue regeneration.
Vilon 20 mg
Dragon Pharma Vilon 20 mg – Synthetic Dipeptide for Immune and Chromatin Research ✔ Synthetic Lys-Glu dipeptide bioregulator ✔ Khavinson peptide class compound ✔ Studied for immune modulation & chromatin remodeling ✔ USA domestic shipping available Dragon Pharma Vilon 20 mg is a synthetic dipeptide with the amino acid sequence Lys-Glu (KE). Developed as part of the well-characterized Khavinson class of short peptide bioregulators, this compound has been investigated in laboratory and animal models for its potential role in immune modulation, chromatin remodeling, and gene expression changes associated with cellular aging. Each vial contains 20 mg of lyophilized Vilon in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Vilon represents a minimal yet biologically active peptide tool for investigating fundamental cellular processes including immune function, epigenetic regulation, and the molecular basis of cellular aging. For related research compounds, explore our peptides category and specifically Epitalon 50 mg for complementary aging and telomere research applications. What Makes Vilon Valuable in Research? Vilon is a remarkably short peptide consisting of just two amino acids, yet it demonstrates significant biological activity in research models. The Lys-Glu dipeptide has been studied for its ability to influence immune cell function, modulate chromatin structure, and affect gene expression patterns associated with cellular aging. Its simplicity and specificity make it a valuable tool for investigating the molecular mechanisms of peptide bioregulation. Researchers value Vilon for its fundamental role in studying peptide-mediated cellular regulation. Its ability to influence immune responses and chromatin dynamics provides insights into the mechanisms that govern cellular function, gene expression, and the aging process. For investigators exploring other aspects of immune function, Thymosin Alpha-1 offers complementary research avenues in immune system regulation. Current scientific literature on Khavinson peptides, including Vilon, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications. Key Research Applications for Dragon Pharma Vilon ✔ Investigation of immune modulation and function ✔ Evaluation of chromatin remodeling and epigenetic regulation ✔ Research on gene expression changes in cellular aging ✔ Studies of peptide bioregulation in immune cells ✔ Preclinical models of aging and immune function For Research Purposes Only Vilon 20 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on cellular regeneration, Livagen 20 mg provides additional research avenues in chromatin remodeling and gene expression.